| Attribute |
Value |
| 52 Week Change |
0.025316477 |
| Address1 |
115 Pullman Crossing Road |
| Address2 |
Suite 103 |
| All Time High |
7.0 |
| All Time Low |
1.12 |
| Ask |
1.75 |
| Ask Size |
5,200 |
| Average Analyst Rating |
1.3 - Strong Buy |
| Average Daily Volume10 Day |
1,327,010 |
| Average Daily Volume3 Month |
831,842 |
| Average Volume |
831,842 |
| Average Volume10Days |
1,327,010 |
| Bid |
0.0 |
| Bid Size |
2,900 |
| Book Value |
-0.276 |
| City |
Grasonville |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
1.66 |
| Current Ratio |
0.054 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
1.69 |
| Day Low |
1.62 |
| Display Name |
OS Therapies |
| Earnings Timestamp |
1,779,134,400 |
| Earnings Timestamp End |
1,786,710,600 |
| Earnings Timestamp Start |
1,786,710,600 |
| Ebitda |
-33,386,824 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-2.259 |
| Enterprise Value |
75,429,352 |
| Eps Current Year |
-0.77667 |
| Eps Forward |
0.36 |
| Eps Trailing Twelve Months |
-1.1 |
| Esg Populated |
0 |
| Exchange |
ASE |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
1.7786 |
| Fifty Day Average Change |
-0.11860001 |
| Fifty Day Average Change Percent |
-0.06668167 |
| Fifty Two Week Change Percent |
2.5316477 |
| Fifty Two Week High |
2.57 |
| Fifty Two Week High Change |
-0.90999997 |
| Fifty Two Week High Change Percent |
-0.3540856 |
| Fifty Two Week Low |
1.15 |
| Fifty Two Week Low Change |
0.51 |
| Fifty Two Week Low Change Percent |
0.44347826 |
| Fifty Two Week Range |
1.15 - 2.57 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,722,519,000,000 |
| Float Shares |
36,208,144 |
| Forward Eps |
0.36 |
| Forward P E |
4.6111107 |
| Free Cashflow |
-1,444,528 |
| Full Exchange Name |
NYSE American |
| Full Time Employees |
4 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.22136 |
| Held Percent Institutions |
0.06463 |
| Implied Shares Outstanding |
44,538,106 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Long Business Summary |
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland. |
| Long Name |
OS Therapies Incorporated |
| Market |
us_market |
| Market Cap |
73,933,248 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_580518990 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
-35,273,816 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
72,151,731 |
| Number Of Analyst Opinions |
5 |
| Open |
1.63 |
| Operating Cashflow |
-15,360,230 |
| Operating Margins |
0.0 |
| Payout Ratio |
0.0 |
| Phone |
410 297 7793 |
| Pre Market Change |
-0.029999971 |
| Pre Market Change Percent |
-1.8072273 |
| Pre Market Price |
1.63 |
| Pre Market Time |
1,784,107,734 |
| Previous Close |
1.62 |
| Price Eps Current Year |
-2.1373298 |
| Price Hint |
4 |
| Price To Book |
-6.014493 |
| Profit Margins |
0.0 |
| Quick Ratio |
0.054 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
strong_buy |
| Recommendation Mean |
1.25 |
| Region |
US |
| Regular Market Change |
0.04 |
| Regular Market Change Percent |
2.46913 |
| Regular Market Day High |
1.69 |
| Regular Market Day Low |
1.62 |
| Regular Market Day Range |
1.62 - 1.69 |
| Regular Market Open |
1.63 |
| Regular Market Previous Close |
1.62 |
| Regular Market Price |
1.66 |
| Regular Market Time |
1,784,059,200 |
| Regular Market Volume |
450,520 |
| Return On Assets |
-3.6663 |
| Sand P52 Week Change |
0.20365608 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
44,538,106 |
| Shares Percent Shares Out |
0.0506 |
| Shares Short |
2,251,861 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
1,657,466 |
| Short Name |
OS Therapies Incorporated |
| Short Percent Of Float |
0.0546 |
| Short Ratio |
2.95 |
| Source Interval |
15 |
| State |
MD |
| Symbol |
OSTX |
| Target High Price |
13.0 |
| Target Low Price |
6.0 |
| Target Mean Price |
8.918 |
| Target Median Price |
8.0 |
| Total Cash |
917,552 |
| Total Cash Per Share |
0.021 |
| Total Debt |
1,342,942 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-1.1 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
1.6489 |
| Two Hundred Day Average Change |
0.011099935 |
| Two Hundred Day Average Change Percent |
0.0067317206 |
| Type Disp |
Equity |
| Volume |
450,520 |
| Website |
https://ostherapies.com |
| Zip |
21,638 |